TODAY ONLY! For only $7, you can get 2 winning options trade alerts every month! Click Here to See Trade Ideas! (Risk-free with a 14 day refund guarantee)
NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Oak Street Health, Inc. ("Oak Street" or the "Company") (NYSE: OSH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
If you are looking for the perfect trading strategy tailored to your preferances then click here to take our FREE Benzinga Trader Strategy Quiz!
The investigation concerns whether Oak Street and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On November 8, 2021, Oak Street filed its quarterly report with the U.S. Securities and Exchange Commission on Form 10-Q for the quarter ended September 30, 2021. Therein, Oak Health disclosed, in relevant part, that on November 1, 2021 the Company received a civil investigative demand ("CID") from the United States Department of Justice ("DOJ"). According to the CID, the DOJ is investigating whether the Company violated the False Claims Act. The CID also requests documents and information related to the Oak Street's relationships with "third-party marketing agents" and Oak Street's "provision of free transportation to federal health care beneficiaries."
On this news, Oak Street's...
The DBM released P362 million to accelerate recovery efforts, while a House bill is seeking a P15-billion supplemental budget for Mindanao quake victims Claim: No budget has been allotted to help ...